182 related articles for article (PubMed ID: 35588750)
1. Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: a randomised controlled trial.
Lv Y; Chen H; Luo B; Bai W; Li K; Wang Z; Xia D; Guo W; Wang Q; Li X; Yuan J; Cai H; Xia J; Yin Z; Fan D; Han G
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):736-746. PubMed ID: 35588750
[TBL] [Abstract][Full Text] [Related]
2. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
[TBL] [Abstract][Full Text] [Related]
4. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
[TBL] [Abstract][Full Text] [Related]
5. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
7. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
[TBL] [Abstract][Full Text] [Related]
8. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study.
Yu J; Wang X; Jiang M; Ma H; Zhou Z; Yang L; Li X
Eur Radiol; 2019 Feb; 29(2):699-706. PubMed ID: 30039223
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.
Pomier-Layrargues G; Villeneuve JP; Deschênes M; Bui B; Perreault P; Fenyves D; Willems B; Marleau D; Bilodeau M; Lafortune M; Dufresne MP
Gut; 2001 Mar; 48(3):390-6. PubMed ID: 11171831
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Transjugular Intrahepatic Portosystemic Shunt Plus Partial Splenic Embolization for the Treatment of Patients with Recurrent Variceal Bleeding.
Li YH; Wu JF; Wu HM; Wu XN; Xu Y; Wan YM
Acad Radiol; 2020 Mar; 27(3):323-331. PubMed ID: 31147236
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial.
Gülberg V; Schepke M; Geigenberger G; Holl J; Brensing KA; Waggershauser T; Reiser M; Schild HH; Sauerbruch T; Gerbes AL
Scand J Gastroenterol; 2002 Mar; 37(3):338-43. PubMed ID: 11916197
[TBL] [Abstract][Full Text] [Related]
12. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients.
Meddi P; Merli M; Lionetti R; De Santis A; Valeriano V; Masini A; Rossi P; Salvatori F; Salerno F; de Franchis R; Capocaccia L; Riggio O
Hepatology; 1999 Apr; 29(4):1074-7. PubMed ID: 10094949
[TBL] [Abstract][Full Text] [Related]
14. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
Holster IL; Tjwa ET; Moelker A; Wils A; Hansen BE; Vermeijden JR; Scholten P; van Hoek B; Nicolai JJ; Kuipers EJ; Pattynama PM; van Buuren HR
Hepatology; 2016 Feb; 63(2):581-9. PubMed ID: 26517576
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization.
Schultheiß M; Giesler M; Maruschke L; Schmidt A; Sturm L; Thimme R; Rössle M; Bettinger D
Cardiovasc Intervent Radiol; 2019 May; 42(5):729-736. PubMed ID: 30788517
[TBL] [Abstract][Full Text] [Related]
16. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment.
Zhang H; Xiao J; Tu J; Zhang M; Zhang F; Yin Q; Zhuge Y
Eur J Gastroenterol Hepatol; 2021 May; 33(5):752-761. PubMed ID: 33731589
[TBL] [Abstract][Full Text] [Related]
17. Secondary prophylaxis of oesophageal variceal haemorrhage: a role for transjugular intrahepatic portosystemic shunt?
Harrison P; Karani J
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):591-3. PubMed ID: 12072591
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.
Rössle M; Deibert P; Haag K; Ochs A; Olschewski M; Siegerstetter V; Hauenstein KH; Geiger R; Stiepak C; Keller W; Blum HE
Lancet; 1997 Apr; 349(9058):1043-9. PubMed ID: 9107241
[TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).
Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P
Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy for prevention of variceal rebleeding in patients with hepatocellular carcinoma meeting the Milan criteria.
Luo J; Li M; Wu C; Zhu D; Wang H; Huang M; Jiang Z
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):436-442. PubMed ID: 32398493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
